Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effectiveness and Safety of DNL310 vs Idursulfase for Children and Young Adults with Mucopolysaccharidosis Type II

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Belgium Czechia France Germany Italy The Netherlands +2
  • Study on Long-Term Safety of Idursulfase-IT and Elaprase for Patients with Hunter Syndrome and Cognitive Impairment

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Long-term Safety and Efficacy Study of JR-141 (Pabinafusp Alfa) for Male Patients with Hunter Syndrome (Mucopolysaccharidosis II)

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Spain
  • Study on Long-Term Safety and Effects of DNL310 for Patients with Mucopolysaccharidosis Type II (MPS II)

    Recruiting

    3 1 1
    Investigated Diseases:
    Belgium Czechia France Germany Italy The Netherlands +2
  • Study on the Effects and Safety of JR-141 and Idursulfase for Patients with Hunter Syndrome

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France Germany Italy Poland Spain
  • Study on the Safety of DNL310 for Children with Hunter Syndrome

    Not recruiting

    2 1 1
    Investigated Diseases:
    The Netherlands